Advertisement
The Body: The Complete HIV/AIDS Resource Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Home Page for TheBody.com, the Complete HIV/AIDS Resource What's New About HIV Ask the Experts About HIV HIV/AIDS Blogs Connect With Others About HIV Just Diagnosed With HIV HIV Treatment HIV Prevention Living With HIV Personal Stories of People With HIV
   
Ask the Experts About

Managing Side Effects of HIV TreatmentManaging Side Effects of HIV Treatment
           
Rollover images to visit our other forums!
Recent AnswersAsk a Question
  
  • Email Email
  • Glossary Glossary


R278474
Dec 17, 2004

What do you know about R278474?

Has it been presented at any conferences? Why has the media made such a big deal about it?

Response from Dr. Henry

R278474 (also known as DAPYs) is a new compound developed at Rutgers University which inhibitors HIV reverse transciptase. Pre-clinical studies have been positive and I believe the first human studies are being planned. I have not seen in human/clinical data so I cannot comment further. KH



Previous
AIDS Diagnosis		Next
Avascular necrosis and HIV Link?

  
  • Email Email
  • Glossary Glossary
 Get Email Notifications When This Forum Updates or Subscribe With RSS


 
Advertisement


Q&A TERMS OF USE

This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint

Advertisement